NAD+ and peptide therapies are provided on an elective basis and are not FDA-approved to treat, cure, or prevent any disease. Certain peptides may be subject to FDA restrictions. Individual results vary.
Some therapies described on this site are not approved by the U.S. Food and Drug Administration (FDA) for the uses discussed and may be provided on an off-label or elective basis at the discretion of a licensed physician. “Off-label” means a treatment is used in a way not specified in the FDA’s approved labeling. The risks, benefits, and alternatives of any therapy will be reviewed with you during an individualized consultation and informed- consent process.
The information on this page is provided for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any medical condition or before beginning any treatment. Individual results vary and are not guaranteed, and nothing on this page is a promise or guarantee of any specific outcome. Castle Rock Regenerative Healthcare does not claim to diagnose, treat, cure, or prevent any disease except as expressly stated and permitted by law.
Medically reviewed by Scott E. Faulkner, MD, board-certified in Internal Medicine, Medical Director of Castle Rock Regenerative Healthcare. Last reviewed June 26, 2026.
Scott E. Faulkner, MD, is the Medical Director of Castle Rock Regenerative Healthcare and the clinical lead behind its regenerative and longevity medicine programs. Board-certified in Internal Medicine, Dr. Faulkner practices regenerative and stem cell medicine and draws on experience in intensive care (ICU) settings, where precision and patient safety are paramount. He is affiliated with the American Academy of Anti-Aging Medicine (A4M). Dr. Faulkner is known for explaining treatments in plain language, at the cellular level, so patients understand both what a therapy may offer and what it cannot. He oversees the clinical standards for every service offered at CRRH.